Peptide Sciences shut down in March 2026 after generating $7.4 million per month
You should not be left to deal with unexpected, life-changing vision loss alone
And you know, the way around that is again, if we're not doing pharmaceuticals, is to maintain these healthy lifestyle choices
In the intention-to-treat (ITT) analysis, cohort members were followed from index date until first registration of suicide or suicide attempts, emigration, death, switching to the other study drug or end of follow-up (31 December 2022)
Retatrutides 24.2% weight loss result comes from a 338-person Phase 2 trial with a relatively homogeneous population it cannot be directly compared to Tirzepatides 2,539-person Phase 3 SURMOUNT-1 data without acknowledging this statistical limitation